amoxicillin and clavulanate potassium drops- amoxicillin and clavulanate potassium suspension
cronus pharma llc - amoxicillin anhydrous (unii: 9em05410q9) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin and clavulanate potassium for oral suspension drops are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin and clavulanate potassium for oral suspension has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, pasteurella multocida, and pasteurella spp. urinary tract infection
amoxicillin and clavulanate potassium drops- amoxicillin and clavulanate potassium suspension
covetrus - amoxicillin anhydrous (unii: 9em05410q9) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin and clavulanate potassium for oral suspension drops are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin and clavulanate potassium for oral suspension has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, pasteurella multocida, and pasteurella spp. urinary tract infection
amoxicillin and clavulanate potassium powder, for suspension
dechra veterinary products llc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin and clavulanate potassium for oral suspension drops are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus , staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin and clavulanate potassium for oral suspension has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus , staphylococcus spp., streptococcus spp., e. coli , pasteurella multocida , and pasteurella spp. urinary tract infe
betacillin drops- amoxicillin and clavulanate potassium suspension
mwi animal health - amoxicillin anhydrous (unii: 9em05410q9) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - betacillin drops are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. betacillin drops has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, pasteurella multocida, and pasteurella spp. urinary tract infections (cystitis) due to susceptible strains of e. coli . therapy may be initiated with betac
umbrellin- amoxicillin and clavulanate potassium suspension
aspen veterinary resources ltd - amoxicillin anhydrous (unii: 9em05410q9) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - umbrellin™ drops are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. umbrellin™ drops has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, pasteurella multocida, and pasteurella spp. urinary tract infections (cystitis) due to susceptible strains of e. coli . therapy may be initiated with umbre
amoxicillin and clavulanate potassium tablet, coated
cronus pharma llc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - indications: amoxicillin and clavulanate potassium tablets are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli. periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin and clavulanate potassium tablets have been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, and pasteurella spp. urinary tract infections (cystitis) due to susceptible st
amoxicillin and clavulanate potassium tablet, coated
covetrus - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - indications: amoxicillin and clavulanate potassium tablets are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli. periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin and clavulanate potassium tablets have been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, and pasteurella spp. urinary tract infections (cystitis) due to susceptible st
clavamox- amoxicillin and clavulanate potassium tablet, chewable
zoetis inc. - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 50 mg - clavamox chewable tablets are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli. periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. clavamox chewable has been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non-β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, and pasteurella spp. urinary tract infections (cystitis) due to susceptible strains of e. coli. therapy may be initiated with clavamox chewab
amoxicillin trihydrate and clavulanate potassium- amoxicillin trihydrate, clavulanate potassium tablet
putney, inc. - amoxicillin anhydrous (unii: 9em05410q9) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 50 mg - indications: amoxicillin trihydrate and clavulanate potassium tablets are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus , staphylococcus spp., streptococcus spp., and e. coli . periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. amoxicillin trihydrate and clavulanate potassium tablets have been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus , non-β-lactamase-producing staphylococcus aureus , staphylococcus spp., streptococcus spp., e. coli , and pasteurella spp. urinary tract infections (cystitis)
betacillin- amoxicillin and clavulanate potassium tablet, coated
mwi animal health - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - indications: betacillin tablets are indicated in the treatment of: dogs: skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., and e. coli. periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. betacillin tablets have been shown to be clinically effective for treating cases of canine periodontal disease. cats: skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing staphylococcus aureus, non- β-lactamase-producing staphylococcus aureus, staphylococcus spp., streptococcus spp., e. coli, and pasteurella spp. urinary tract infections (cystitis) due to susceptible strains of e. coli. therapy may be initiated with betaci